Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: firstname.lastname@example.org
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Floods, landslides kill 75, displace thousands in eastern India
3 Aug 2015 at 4:17am
At least 75 people have died and tens of thousands have had to take refuge in state-run relief camps after heavy rains caused floods and landslides in eastern India, government officials and aid groups said on Monday. Exacerbated by Cyclone Komen which struck the east coast on Friday, the rainfall has made major rivers overflow, inundating villages in parts of West Bengal, Odisha and Manipur states. Banerjee said the release of water from over-full dams in the neighboring states of Jharkhand and Odisha had worsened the flooding in West Bengal, where at least 49 people have died.
Samsung Electronics to create fund for cancer-stricken workers, safety
3 Aug 2015 at 3:35am
Tech giant Samsung Electronics Co Ltd said on Monday it will create a 100 billion won ($85.8 million) fund to compensate cancer-stricken workers and their families, and for efforts to prevention such diseases at its chip and display factories. Samsung said in a statement the fund will make payments to workers or families of those who became sick while working at its plants, including contractors. South Korean activist group Sharps, which represents many of the cancer-stricken workers, said on Monday it was aware of around 200 workers who had fallen ill after working at a Samsung plant.
Western companies look hard at China as growth slows
3 Aug 2015 at 2:41am
The Chinese slowdown is forcing many Western companies to take a hard look at their businesses there, leading many to reduce investments, costs and product lines and to tackle increasing bad debts. Double digit growth rates during the first decade of the millennium lured scores of Western companies to invest heavily in China. A recent equities market rout has dashed hopes China will, in the coming years, return to the robust growth it saw in the past.
South Africa's Ascendis to buy 49 pct stake in Spain's Farmalider
3 Aug 2015 at 2:25am
Ascendis Health will pay 210 million rand ($16.58 million) for 49 percent of Spain's Farmalider, the South African pharmaceutical company said on Monday. The South African group will have an option to up its stake in Farmalider to 80 percent by the end of 2018 and to buy the rest of the Spanish company's shares by the end of 2020.
Environmental racism persists, and the EPA is one reason why
3 Aug 2015 at 2:00am
Many communities of color in America suffer environmental discrimination. The EPA office created to help them has done little.
Privatizing Medicare would create more problems than it solves
3 Aug 2015 at 2:00am
Commentary: federal health program celebrating 50 years of helping the elderly
How we acquired and analyzed data for "Environmental Justice, Denied"
3 Aug 2015 at 2:00am
How the Center acquired and analyzed data for its investigation of the EPA's Office of Civil Rights.
Decades of inaction
3 Aug 2015 at 2:00am
In its 23-year history, the civil-rights office has never once made a formal finding of a Title VI violation.
Planned Parenthood fight hits Congress, wider impact unclear
3 Aug 2015 at 1:25am
By Richard Cowan and Alex Wilts WASHINGTON, August 3 (Reuters) - Women's health group Planned Parenthood, under attack by anti-abortionists posting hidden-camera videos online, will be the focus of a partisan showdown on Monday in the U.S. Senate, with any wider influence on voters from the charge still unclear. Congressional Republicans are trying to cut off Planned Parenthood's federal funding. The Senate plans to hold a procedural vote on Monday on a Republican proposal to cut off the funds.
5 things to know about the fight over Planned Parenthood
3 Aug 2015 at 12:25am
WASHINGTON (AP) ? Republicans will likely lose Monday's Senate showdown over halting federal aid to Planned Parenthood. Yet the political offensive by abortion foes has just started, prompted by a batch of unsettling videos that has focused attention on the group's little-noticed practice of providing fetal tissue to researchers.
Hard liquor: Officials seize Chinese spirits laced with Viagra
3 Aug 2015 at 12:21am
Chinese authorities have seized thousands of bottles of spirits laced with chemicals used to make erectile dysfunction drugs such as Viagra, officials said. Two manufacturers in Liuzhou were found to be adding elements including sildenafil and tadalafil, the chemicals more commonly known by their brand names Viagra and Cialis, to their baijiu products, the local food and drug administration said in a statement. The makers called their products "Kungfu Alcohol" and "Life-nourishing Liquor", among other labels, authorities in the southern region of Guangxi said at the weekend, adding they had seized more than 5,300 bottles and nearly 1,200 kilograms of additive chemicals.
Olympics-Rio water quality on agenda as IOC leaves for Brazil
2 Aug 2015 at 11:45pm
By Karolos Grohmann KUALA LUMPUR, Aug 3 (Reuters) - The water quality for competitors at the 2016 Rio de Janeiro Olympics will be on the agenda when the International Olympic Committee travels to Brazil for talks this week, IOC President Thomas Bach said on Monday. Bach is leaving for the Brazilian city later in the day to attend celebrations marking the one year countdown to the Games on Aug. 5 and said pollution would be discussed with Rio 2016 officials. Privately commissioned tests of the water quality where athletes will be competing revealed last week a high level of disease-causing viruses.
Nine-year-old Kansas batboy dies after blow to head
2 Aug 2015 at 10:42pm
A 9-year-old batboy for a Kansas baseball team died on Sunday after being accidentally struck in the head by a player taking practice swings while waiting for his turn at the plate, the team said. Kaiser Carlisle was knocked unconscious by the blow to the back of his head from a batter warming up during a game on Saturday in Wichita, bringing play to a halt as emergency medical personnel rushed onto the field, the Liberal Bee Jays baseball team said. Kaiser was serving as a batboy for the team from Liberal, Kansas, competing in the National Baseball Congress World Series, which consists of teams from 15 amateur and semi-professional leagues in the United States and Canada.
Most picky eating harmless but it can signal emotional woes
2 Aug 2015 at 9:53pm
CHICAGO (AP) ? Parents of picky eaters take heart: New research suggests the problem is rarely worth fretting over, although in a small portion of kids it may signal emotional troubles that should be checked out.
New cocktails to test limits of cancer drug pricing
2 Aug 2015 at 9:03pm
By Ben Hirschler LONDON (Reuters) - New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. The growing reluctance of governments and private insurers to fund very expensive drugs - even remarkably effective ones - points to a showdown as manufacturers mix and match therapies that harness the immune system to fight tumors. Dozens of new cancer combinations will be launched over the next few years, with ones for lung cancer, melanoma and other solid tumors taking off strongly after 2018, drug company pipelines suggest.